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Abstract
Primary intestinal lymphangiectasia (PIL), also known as Waldmann’s disease, is a rare disorder manifested 
by the presence of dilated intestinal lymphatic ducts and leading to protein-losing enteropathy. PIL usually 
presents early in childhood; however, rarely may be also diagnosed in adults. Suggestive laboratory findings 
include hypoproteinemia, hypoalbuminemia, and hypogammaglobulinemia. Peripheral pitting edema due to 
hypoalbuminemia is the main clinical feature. Peripheral lymphedema is a less common symptom. We present 
a case of a 23-year-old woman with lymphedema of lower extremities and PIL diagnosed in childhood.
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Introduction
Primary intestinal lymphangiectasia (PIL), also known as 
Waldmann’s disease, is a rare disorder, resulting from 
the presence of dilated intestinal lymphatic ducts and 
leading to protein-losing enteropathy. Dilated intestinal 
lymphatics lead to lymph leakage into the lumen of the 
small intestine and consequently, to hypoalbuminemia, 
hypogammaglobulinemia, lymphopenia, and in severe 
cases to generalized edema. PIL usually occurs in chil-
dren before 3 years of age and adolescents, but rarely 
may be also diagnosed in adults [1, 2]. We described 
a case of a 26-year-old woman with lymphedema of 
lower extremities and PIL diagnosed in childhood. 
Case report
A 26-year-old woman was referred to the Department 
of Angiology, Hypertension and Diabetology at Wro-
claw Medical University because of edema of lower 
extremities. The lower limb edema was observed for 
the first time at the age of six months and has gradually 
progressed. The medical history of the patient revealed 
a very typical course of primary intestinal lymphangiec-
tasia (PIL). Shortly after birth, temporary swelling of the 
labia appeared. The edema of the lower extremities was 
the next symptom. Until the age of five, the patient was 
repeatedly hospitalized due to recurrent respiratory 
infections accompanied by hypoalbuminemia (21 g/L), 
hypoproteinemia (42 g/L), hypogammaglobulinemia 
(IgG: 2–3.5 g/l; IgA: 0.16 g/l) and lymphopenia (10%). 
The endoscopic examination of the gastrointestinal tract 
and albumin scintigraphy did not clearly confirm the 
PIL. The abdominal computed tomography (CT) and 
magnetic resonance imaging (MRI) have shown small 
intestine thickening with slight ascites. Finally, at the 
age of five, the patient underwent a laparotomy, which 
revealed the presence of intestinal lymphangiectasia. 
Histopathological examination of biopsy specimens 
taken during laparotomy established the suspected di-
agnosis of PIL. Since childhood the patient did not suffer 
from any recurrent abdominal pain, nausea, vomiting, 
weight loss, obstructive ileus, or steatorrhea. The lower 
extremity edema during the current hospitalization 
was the dominant clinical symptom, which significantly 
affected the everyday life of the patient (Fig. 1). Diet 
therapy with medium-chain triglycerides (MCT) has 
been applied since the diagnosis of PIL. In the past, the 
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patient was also treated with intravenous immunoglob-
ulins, intravenous fresh frozen plasma, and octreotide. 
However, these therapies resulted in only temporary 
improvement of hematological and scintigraphy findings. 
The patient has never been treated with compression 
therapy because of the leg lymphedema. 
On a phys ical examination performed during the 
current hospitalization, the scar after laparotomy and 
moderate periph eral edema of lower extremities, with 
Stemmer’s sign and skin thickening, was noted. The 
laboratory studies revealed hypoalbuminemia and hy-
pogammaglobulinemia. The lymphoscintigraphy of the 
lower extremities revealed the lack of visible lymphatic 
trunks in both legs and of the inguinal lymph nodes on 
the right side. Dermal backflow was also noticeable 
within the calves (Fig. 2). The compression therapy, 
Figure 1. Lymphedema of the lower extremities in our patient. In the second photo the patient is wearing the compression 
stockings, which are the basic treatment of lymphedema
Figure 2. Lymphoscinthigraphy showing the lack of visualization of the lymphatic trunks in both legs and of the inguinal lymph nodes 
on the right side. Dermal backflow is also visible within the calves
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firstly with low-stretch bandages and secondly with 
compression stockings, has been started with the good 
clinical effect of lymphedema reduction. The sirolimus, 
a mammalian target of rapamycin (mTOR) inhibitor 
and/or intestine microsurgery has been considered for 
further treatment. 
Discussion
Primary intestinal lymphangiectasia (PIL) is a rare pro-
tein-losing enteropathy of unknown prevalence. Less 
than 200 cases have been reported since 1961 when 
Waldmann et al. described the first 18 cases of the dis-
ease [1].⁠ The etiology of PIL is unknown. It is caused 
by congenital malformation or obstruction of intestine 
lymphatics with concomitant increased intraluminal 
pressure. The disease can affect all small intestine or 
maybe segmental. It leads to dilatation of lymphatic 
vessels in mucosa, submucosa, and subserosa and lymph 
leakage into the small bowel lumen resulting in hypoal-
buminemia, hypogammaglobulinemia, and lymphopenia 
[1, 2].⁠ The basic clinical feature is peripheral pitting 
edema of variable degree, usually symmetrical, due to 
low oncotic pressure usually involving lower limbs, face, 
external genitalia, scrotum, or vagina. Serous effusions 
in more severe cases are also common — pleural effu-
sion, chylous ascites, and pericarditis may be present in 
patients and may be life-threatening. Other concomi-
tant symptoms are abdominal pain, nausea, vomiting, 
moderate diarrhea, fat-soluble vitamin deficiencies, and 
weight loss [2–5]. In our patient, there were no diges-
tive symptoms all the time. However, diet therapy was 
applied just after the diagnosis of PIL. The swelling of 
the labia was the earliest symptom of the disease in our 
patient. Lymphedema of lower extremities was the next 
clinical feature. Lymphedema of lower limbs is a rarer 
symptom in PIL [1]. Lymphedema of upper extremities, 
breast, and external genitalia were also noted [6]. At 
the age of 26, lymphedema of lower limbs affected our 
patient’s quality of life the most. However, compression 
therapy was started scarcely during hospitalization in 
our Department. 
The diagno sis of PIL in our patient was based on the 
clinical course, laparotomy, and histopathological find-
ings of intestine specimens taken during laparotomy. At 
present, endoscopy with histopathological assessment 
of intestine biopsy is the most important tool in PIL 
diagnostics [1]. The laboratory findings of hypoproteine-
mia, hypoalbumin emia, hypogammaglobulinemia, and 
lymphocytopenia may be suggestive. The macroscopic 
abnormalities which may be found during small bowel 
endoscopy include scattered whitish spots (snowflake 
appearance), thickened villi, and edematous mucosa 
of the small intestine [7]. Although capsule endoscopy 
cannot be used to perform a biopsy, it is a comforta-
ble method to examine mucosa of the small intestine 
[1, 7, 8]. Radiologic examinations also can be useful. 
Ultrasonography has the potential to show dilation of 
the intestinal loops, regular and diffuse thickening of the 
walls, plical hypertrophy and mesenteric edema [9]. CT 
may reveal thickening and edema of small intestine wall, 
as a consequence of the dilated lymphatics [10, 11]. 
Moreover, Sun et al. documented a new diagnostic 
method of multiple-detector computed tomography 
(MDCT) after direct lymphangiography in 55 patients 
with PIL. In this study, intra- and extraintestinal abnor-
malities, especially regarding the morphology and the 
extent of lymphatic vessel involvement were observed.⁠ 
Therefore, it can be a significant tool for the diagnosis of 
PIL [12]. Lymphoscintigraphy is a useful diagnostic tool 
for identifying abnormal lymphatics within the upper 
and lower extremities [1, 13].
The rarity of PIL is the reason for the lack of treat-
ment guidelines in this disorder. Dietary intervention 
is the gold standard in PIL management. A low-fat and 
high-protein diet supplemented with medium-chain 
triglycerides (MCT) is usually recommended [7, 8]. 
The majority of PIL children respond to dietary therapy 
and according to Prasal et al. only 20% need additional 
therapy [14]. Lipid elements in food provoke lymphatic 
pressure increase and lymphatic leakage into the small 
bowel lumen. A low-fat diet reduces lymphatic flow and 
lacteal dilation and thus helps to prevent lymph loss. 
MCTs are absorbed directly in portal venous circula-
tion by passing the lymphatic system and thus provide 
nutrient fat and lessens lacteal engorgement [2]. Other 
treatment methods can be used in the combination with 
a low-fat diet with MCT supplementation, mostly in 
severe cases. These are as follows: octreotide (150–200 
ug twice a day or slow-release formulation), tranexamic 
acid (1 g, 3 times a day), antiplasmin, corticosteroids, 
vitamin D supplementation, albumin infusion (applied in 
patients with significant serous effusion) [1, 15]⁠. In the 
cases with segmental lesions within intestine, surgical 
procedures as small bowel resection may be recom-
mended [16]. Recently, the successful use of mTOR 
inhibitors (sirolimus, everolimus) in the treatment of 
a small collection of vascular anomalies and PIL has 
also been reported [17, 18]. Lymphedema of upper 
and lower extremities should be treated with stand-
ard compression therapy, including complex physical 
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